Apolipoprotein E genetic polymorphism influence the susceptibility to nephropathy in type 2 diabetes patients

被引:11
作者
Atageldiyeva, Kuralay K. [1 ]
Nemr, Rita [2 ]
Echtay, Akram [3 ]
Racoubian, Eddie [4 ]
Sarray, Sameh [5 ,6 ]
Almawi, Wassim Y. [1 ,6 ]
机构
[1] Nazarbayev Univ Astana, Sch Med, Astana, Kazakhstan
[2] Rizk Hosp, LAU Med Ctr, Dept Internal Med, Beirut, Lebanon
[3] Rafic Henri Univ Hosp, Dept Adult Endocrinol & Diabet, Beirut, Lebanon
[4] St Marc Med Ctr, Beirut, Lebanon
[5] Arabian Gulf Univ, Coll Med & Med Sci, Manama, Bahrain
[6] El Manar Univ, Fac Sci, Tunis, Tunisia
关键词
Apolipoprotein E; Diabetic nephropathy; Genotyping; Type 2 diabetes mellitus; E EPSILON-4 ALLELE; ALZHEIMERS-DISEASE; ASSOCIATION; APOE; LEBANESE; LIPOPROTEINS; ALBUMINURIA; POPULATIONS; FREQUENCY; VARIANTS;
D O I
10.1016/j.gene.2019.144011
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: An association between Apolipoprotein E (Apo E) alleles and genotypes and diabetic nephropathy (DN) was suggested, but with inconsistent results. We tested the relationship between serum lipids, Apo E alleles and genotypes with type 2 diabetes (T2DM), and DN pathogenesis. Methods: Study subjects comprised 1389 normoglycemic controls, and 1422 T2DM patients, of whom 825 were normoalbuminuric (DWN), and 597 presented with nephropathy (DN). Results: Significantly lower Apo epsilon 2, and higher Apo epsilon 4 allele frequencies was seen among T2DM patients than controls. Significantly higher frequency of epsilon 3/epsilon 4, and lower frequencies of epsilon 3/epsilon 3, epsilon 2/epsilon 3, and epsilon 4/epsilon 4 carriers was seen among T2DM cases. Apo epsilon 2-carrying individuals were more frequently found in controls than in patients, while significantly higher frequency of epsilon 4-carrying genotypes was seen in T2DM cases. Significantly higher epsilon 2, and lower epsilon 3 allele frequencies were noted for DN group compared to DWN group. Significantly higher frequency of epsilon 2-containing epsilon 2/epsilon 3 and epsilon 2/epsilon 4, and lower frequencies of epsilon 3/epsilon 3 carriers was seen among DN cases. Apo epsilon 3/epsilon 3 was associated with higher total cholesterol, LDL-cholesterol, and triglyceride levels in DN patients, and significantly higher triglyceride levels were seen in epsilon 2/epsilon 3-carrying DN patients. Logistic regression analysis confirmed the association of Apo epsilon 3-containing epsilon 3/epsilon 3, epsilon 2/epsilon 3, and epsilon 3/epsilon 4, and Apo epsilon 2-containing epsilon 2/epsilon 4 with DN, after controlling for key covariates. Conclusion: The results of this case-control study provide evidence that the epsilon 2 and epsilon 3 alleles of APOE modify lipid profile, and constitute independent risk factors of DN in type 2 diabetes. The molecular mechanisms underlying this risk is discussed.
引用
收藏
页数:7
相关论文
共 53 条
[11]   APOE genotypes in Lebanon: distribution and association with hypercholesterolemia and Alzheimer's disease [J].
El Shamieh, Said ;
Costanian, Christy ;
Kassir, Rayan ;
Visvkis-Siest, Sophie ;
Bissar-Tadmouri, Nisrine .
PERSONALIZED MEDICINE, 2019, 16 (01) :15-23
[12]   The relationship of the apolipoprotein E gene polymorphism in Turkish Type 2 diabetic patients with and without nephropathy [J].
Erdogan, M. ;
Eroglu, Z. ;
Biray, C. ;
Karadeniz, M. ;
Cetinkalp, S. ;
Kosova, B. ;
Gunduz, C. ;
Topcuoglu, N. ;
Ozgen, G. ;
Yilmaz, C. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2009, 32 (03) :219-222
[13]   Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients [J].
Eto, M ;
Saito, M ;
Okada, M ;
Kume, Y ;
Kawasaki, F ;
Matsuda, M ;
Yoneda, M ;
Matsuki, M ;
Takigami, S ;
Kaku, K .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (02) :243-251
[14]   Interleukin-10-592C/A,-819C/T and-1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients [J].
Ezzidi, Intissar ;
Mtiraoui, Nabil ;
Kacem, Maha ;
Mallat, Samir G. ;
Mohamed, Manel Ben Hadj ;
Chaieb, Molka ;
Mahjoub, Touhami ;
Almawi, Wassim Y. .
CLINICAL ENDOCRINOLOGY, 2009, 70 (03) :401-407
[15]   APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome [J].
Fallaize, Rosalind ;
Carvalho-Wells, Andrew L. ;
Tierney, Audrey C. ;
Marin, Carmen ;
Kiec-Wilk, Beata ;
Dembinska-Kiec, Aldona ;
Drevon, Christian A. ;
DeFoort, Catherine ;
Lopez-Miranda, Jose ;
Riserus, Ulf ;
Saris, Wim H. ;
Blaak, Ellen E. ;
Roche, Helen M. ;
Lovegrove, Julie A. .
SCIENTIFIC REPORTS, 2017, 7
[16]   Segregation analysis of urinary albumin excretion in families with type 2 diabetes [J].
Fogarty, DG ;
Hanna, LS ;
Wantman, M ;
Warram, JH ;
Krolewski, AS ;
Rich, SS .
DIABETES, 2000, 49 (06) :1057-1063
[17]   APOE4 Genotype Exerts Greater Benefit in Lowering Plasma Cholesterol and Apolipoprotein B than Wild Type (E3/E3), after Replacement of Dietary Saturated Fats with Low Glycaemic Index Carbohydrates [J].
Griffin, Bruce A. ;
Walker, Celia G. ;
Jebb, Susan A. ;
Moore, Carmel ;
Frost, Gary S. ;
Goff, Louise ;
Sanders, Tom A. B. ;
Lewis, Fiona ;
Griffin, Margaret ;
Gitau, Rachel ;
Lovegrove, Julie A. .
NUTRIENTS, 2018, 10 (10)
[18]   Association between apolipoprotein E polymorphism and macroalbuminuria in patients with non-insulin dependent diabetes mellitus [J].
Ha, SK ;
Park, HS ;
Kim, KW ;
Kim, SJ ;
Kim, DH ;
Kim, JH ;
Lee, HY ;
Han, DS .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (09) :2144-2149
[19]   Pathophysiology of Diabetic Dyslipidemia [J].
Hirano, Tsutomu .
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (09) :771-782
[20]   APOLIPOPROTEIN E2, RENAL-FAILURE AND LIPID ABNORMALITIES IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
HORITA, K ;
ETO, M ;
MAKINO, I .
ATHEROSCLEROSIS, 1994, 107 (02) :203-211